Path Medical Poises for Restructuring

NASDAQ Market News

NEXT STORY
Valneva: U.S. DoD Exercises First Year Option on IXIARO® Supply Contract
PREV STORY
MacroGenics to Participate in Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vical Reports First Quarter 2018 Financial and Operational Results

SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial ...

author_avatar
NASDAQ Market News

Interpace Diagnostics Announces Agreement with Acupath Laboratories

PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

author_avatar
NASDAQ Market News

Biocartis Group NV: Biocartis launches CE-marked IVD NRAS test for colorectal cancer

  PRESS RELEASE: 23 May 2017, 07:00 CEST Biocartis launches CE-marked IVD NRAS test for colorectal ...

author_avatar
NASDAQ Market News